Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

NCT00665431 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: PN 400 (VIMOVO)
DRUG: celebrex
OTHER: Placebo
DRUG: Rescue Antacid

Sponsor

POZEN